chrisvoncsefalvay/vaers-outcomes huggingface dataset:
right ear itching and burning and then the skin started to crack; right ear itching and burning and then the skin started to crack; right ear itching and burning and then the skin started to crack; her other ear was burning, red, felt hot and started cracking again; her other ear was burning, red, felt hot and started cracking again; This is a spontaneous report from a contactable consumer (Patient) via Reporting system.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot number: unknown), via an unspecified route of administration on an unspecified date as dose 2, single, and via an unspecified route of administration on an unspecified date (Lot number: unknown) as dose 1, single for COVID-19 immunization. Medical History included auto-immune disorder. No concomitant medication was reported. It was reported that, about 10 (or 12 days as per reporter) days after receiving the first dose of the vaccine had right ear itching and burning and then the skin started to crack. These side effects lasted about 5 days. About a week after receiving the second dose reports her other ear was burning, red, felt hot and started cracking again. Getting a rash on skin after receiving the second dose, patient thinks the second dose was on or around 30Jun2021. Patient stated that same side effect happened to her sons wifes father and grandfather, that 4 different people from 4 different states have all experienced the exact same side effect after receiving the Pfizer COVID-19 vaccine. She also reported that her 91-year-old mother "hasnt felt right and has had no energy" since she received the Pfizer COVID-19 vaccine in March or April and would like to know if this was something that was being reported specifically with older people. Reporter stated that her mother was usually very active, and now she lays on the couch "50% of the time. The reporter stated that her mom has just been lethargic since her vaccine [Pfizer COVID-19] and something is just not right. Her blood tests are normal and no UTI (urinary tract infection) but she refuses to go back to the doctor, and asking what should she do about this. The outcome of the events was unknown.
Injection site was swollen & red. Pt broke out in hives for a short time. Ice pack placed on site, BENADRYL 25 mg PO given to pt. Vaccines sent back to manufacturer. Some of the vaccines had particles in them. This one did not. Manuf stated OK to use.
At approximately 9:40 AM on Thursday, October 20th, I received a call from patient that she had experienced pain after the injection. She said she had pain since the injection. She had stated she could not move her arm because it was sore and she could not lift anything with the arm that received the injection. She also complained of stomach upset she felt was associated from her arm pain. The patient had been taking her pain medicine as prescribed from her pain doctor. I asked if she had a fever and she said no. I asked if her arm was swollen or felt warm to the touch at the injection site. She stated it was warm at the injection site. I instructed her to place ice on the arm for 20 minutes each hour and to continue her pain medicine (oxycodone/acetaminophen 5-325 mg). She had an appointment with Dr. at 12:15PM on 10/21/16 for her pain medication and the patient inquired about her arm pain. The patient stated her arm was observed and Dr. did not see the necessity for further treatment. At 2:30PM, patient contacted me and she seemed to have improved from the morning. She explained the interaction with Dr. and that their office had recommended to alternate heat and ice therapy. She could move her arm but it was still sore. I explained that the soreness is a common effect from the vaccination and I will continue to contact her until the issue is resolved fully.
Welt on thigh of the injection site, fever, vomiting, and chicken pox outbreak on back, abdomen, and groin.
I was vaccinated and still got Shingles, suspected vaccination failure; still got Shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication. The patient was vaccinated with Shingles vaccine but still got shingles. This case was considered as suspected vaccination failure, since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were not provided.
Broke out with rash all over extremities, trunk, face, bottom of feet 8/12/09.  Has had fever of 100, lethargic, lossof appetitie.  On 8-14-09 some spots have formed blisters.
My Flu symptoms started on 12/21/2022 not sure what time of the day. I had sore throat, cough, runny nose, bad headaches, fever 102, chest congestions and body aches course of couple of days. On 12/28/2022 I went to the primary care office. The doctor prescribed me with an inhaler (fluticasone) and benzonatate. My cough was very intense.
Patient received the pediatric dose of the Hep B vaccine as dose 2 in her 3 dose series.  Dose 1 was given at a different location.  Pt was originally vaccinated for Hep B as a child and is being re-vaccinated for work due to a low titer.  An attempt was made to notify the patient via phone call about the incorrect dosage, but this nurse was unable to leave a voicemail for the patient.
Ringing in her ears; swollen lymph nodes; achy joints, especially her fingers; headache; Initial information received on 29-Oct-2021 regarding an unsolicited valid non-serious case received from non-healthcare professional via Regulatory Authority (RA) (Reference number- 00835123).  This case involves a female patient of unknown age who experienced swollen lymph node (lymphadenopathy), headache, ringing in her ears (tinnitus), achy joints especially fingers (arthralgia) when received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  Patient gets a flu (INFLUENZA VACCINE) shot every year, and usually experiences a headache and achy joints, which resolve quickly.  The patient's medical history, concomitant medication and family history were not provided.   On 05-Oct-2021, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number: UT7325LA and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On 05-OCT-2021 the patient developed a non-serious swollen lymph node (lymphadenopathy), headache, ringing in her ears (tinnitus) persisted for over three weeks, achy joints especially fingers (arthralgia) same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  When the event (tinnitus) persisted for a couple of days, she contacted her healthcare professional.  It was reported "Caller states that she experienced adverse effects from FLUZONE QUADRIVALENT and she is asking for information on how to treat those symptoms. She declined to provide demographics."  Laboratory details were not reported.  The patient was treated with ADVIL [IBUPROFEN] for lymphadenopathy, headache, tinnitus and arthralgia.  The Advil caused resolution of events, except the tinnitus.  On an unknown date, the patient recovered from the events (lymphadenopathy, headache, arthralgia).  At the time of this report, outcome of the events (tinnitus) was not resolved.
Supraclavicular lymph node (mobile, initially mildly tender, 1-2cm, soft) occurring on left side (same side as the vaccine). This was first noted 2 days after vaccination. Associated symptoms including tenderness at the left deltoid (injection site). No fevers, fatigue, night sweats noted.
Approximately 4 hours after the injection I had pain from injection site across shoulder to neck. By evening it had worn off but couldn't move arm to even write. As time went by I was awakened from shoulder pain. Personal physician said pain was from tendon damage from effects of the flu shot. As of the writing of this report I still experience occasional discomfort and have decreased range of motion. Additionally, I was not given a choice of vaccines at that time.
Red around injection site within the first few minutes. We thought maybe it was from when the nurse cleaned his arm with the alcohol pad. Unfortunately, it worsened over the course of the next few hours. His upper arm became sore and swollen and there was a red area approximately 6-inches long and 4-inches wide around the injection site. It resembled a burn. It was also warm to the touch. Applied cold packs, but that did little to lessen the redness or puffiness. This remained for about 3 days, then the visible reaction/symptoms from the vaccine lessened. After 5 days, his arm looked normal again. I can only wonder what other possible side effects he may have due to this vaccine, but which are not easily noticed like a red, swollen arm.
Patient complained of feeling like she "swallowed a feather or a cat hair" - her lungs were tickling.  She said she felt fine, but wanted to be sure to report the "strange feeling".  Patient said she feels well, but wanted to contribute to research.  Patient advised to call 911 or go to the nearest emergency room for any further issues.
nausea, fever, elevated blood pressure, fatigue all currently resolved. This caused to worsen his anxiety which is still presenting effects
received the first dose of the Pfizer COVID-19 vaccine and also recently started taking Depo-Provera. After receiving the first dose of the Pfizer COVID-19 vaccine her daughter developed a blood clot; tired and frail; feels lost and light headed; cramping pain; This is a spontaneous report from a contactable consumer (Patient's mother). A 17-year-old female patient received first dose of BNT162B2 (BNT162B2) via an unspecified route of administration, administered in Arm Right on 03May2021 15:00 (Batch/Lot number was not reported) as 1ST DOSE SINGLE for covid-19 immunization and medroxyprogesterone acetate (DEPO-PROVERA), route of administration, start and stop date, batch/lot number and dose were not reported for contraception. The patient's medical history and concomitant medications were not reported. The patient experienced received the first dose of the pfizer covid-19 vaccine and also recently started taking depo-provera. after receiving the first dose of the pfizer covid-19 vaccine her daughter developed a blood clot, tired and frail, feels lost and light headed and had cramping pain all on unspecified dates. It was reported that after receiving the first dose of the Pfizer COVID-19 vaccine her daughter developed a blood clot. Her daughter, who is currently on Depo Provera got her first dose of the Covid 19 vaccine. The daughter has been experiencing blood clotting and would like to further document this experience. Is also seeking medical advice to inform her daughter. Her daughter Has been on Depo Provera for 4 to 5 months. Since she had the Covid vaccine, she has been having bad blood clotting and has been having a continuous period.  When she got the shot, she has been getting blood clots straight for three weeks. Patient is Tired and frail: She is a waitress, so all of this has made it hard. It started right when she got the shot and has pretty much stayed the same. She will feel like she is lost when she wakes up and is light headed from the loss of blood. It occurs when she is doing activities, like working. Patient took some Midol one day for cramping pain but it barely did anything. The action taken for medroxyprogesterone acetate was unknown. Outcome of tired and frail was not recovered. Outcome of all the other events was unknown.   Information on Lot/Batch number was not available. Additional information has been requested.
17 year old got her first dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old got her first dose of the vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old got her first dose of the vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old got her first dose of the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
real cold chills for over nite . inmorning feeling strange. went to restroom, walking back got real weak, next thing i woke up on the floor about an hour later got up, had the dry heavesthrowing only a small amount of fluid.came up weak all day ,food was not appealing.
PATIENT RECEIVED VACCINE AT 4:15PM ON 5-20-21. EXPERICENCED FEVER, SWEATING, FATIGUE, AND INJECTION SITE PAIN WITHIN HOURS OF VACCINE. NEXT MORNING PATIENT EXPERIENCED ARM, SHOULDER, FINGER OF LEFT ARM MUSCLE SPASMS. LEFT HAND STIFFENED AND LOCKED IN POSTION FOR COUPLE MINUTES DURING DAY. PATIENT DID NOT SEEK MEDICAL ATTENTION BECAUSE SHE SAID SHE WAS TO WEAK TO CALL FOR HELP AND JUST SLEPT. SHE THOUGHT IT WOULD BE BETTER ONCE SHE AWOKE. PATINET DID FEEL SOMEWHAT BETTER NEXT DAY, BUT STILL EXPERIENCING MUSCLE SPASMS AND WEAKNESS AND HAVING DELAYED  RESPONSE FOR MUSCLE CONTRACTION. SPOKE TO MD BECAUSE SHE COULD NOT GET APPOINTMENT 2 DAYS AFTER SHOT AND WAS TOLD TO TAKE TYLENOL, BENADRYL FOR SYMPTOMS.  PATIENT DID NOT SEEK MEDICAL HELP AT ER DUE TO NO INSURANCE COVERAGE.
received the 2nd dose of the Moderna vaccine on Wednesday, February 3rd. The injection was given much higher than the muscle area as the first dose, closer to the shoulder bone. I started that evening with a very intense sore upper arm and tingling in the bottoms of my feet. On yesterday 02/04, I started noticing it in my legs as well and unable to raise my arm above my head without extreme pain. This morning I woke up with the same symptoms and noticed I am dragging my feet slightly as I do not have much feeling in them accompanied by the tingling. I have made an appointment with my PCP for today, 02/05 at 11:30am. I do not have any of the following symptoms: fever, body aches, cough, sore throat, runny nose, loss of taste or smell, SOB, fatigue, chills, or headache.  I can be contacted if needed.   Dx with MS
First night, I had severe chills and sweats off and on throughout the night; including muscle and joint pain that was severe. Fatigue, joint pain and an occasional chill (better then the next day). Monday - Joint pain and occasional chills - those continued for the rest of the week and Wednesday I also had a migraine headache. Friday - severe migraine and vomiting and my doctor sent me to ER.  Medication for the Migraine - three different things - one was an IV Benadryl - the others I don't know. That cleared my symptoms up that same day just a couple hours later. I have been fine every since.
On 09/11/2007 at 8:30 am (4 days post vaccination)observed localized edema, erythema, and hot to the touch at vaccination site on right deltoid. Approximately 160 milimeters in diameter.Client stated on 09/08/07 3:00pm  symptoms consisted of headache,tiredness,and nausea 09/08-09/12/2007.On 09/12/2007 edema and erythema on right deltoid has diminished to 60 milimeters in diameter and symptoms have subsided. Right deltoid no longer hot to the touch.
neck to her fingertips are numb and she can't move it; cold; Runny nose; Congestion; Watering eyes; This is a spontaneous report received from a contactable consumer. A 87-years-old female patient received a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration on an unknown date as single dose for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. The consumer talked to nurse about mom, she had the Pfizer shot yesterday. Her neck to her fingertips were numb and she can't move it. She had cold, congestion, runny eyes, and a running nose. They haven't gone there yet because they were waiting to talk to see what to do. The outcome of the event was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Child is over 3 yrs old, however he was given the pediatric dose of 0.25. We informed parent, and they returned for an additional pediatric dose.
Arm soreness initially, followed by 101-degree fever, chills, muscle aches, cold extremities (hands and feet), fatigue about 12 hours after the vaccine and continuing into the next morning.
Bells palsy left side of face paralyzed went to emergency room on doctors order to rule out stroke given prednisone an an antiviral. Symptoms started to go away in a week. Now about 95 percent normal.
vaccine allergies/she experienced a reaction to the second booster of the Pfizer-BioNTech COVID-19 Vaccine gray cap; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "vaccine allergies" (unspecified if ongoing); "preservative allergies" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for Covid-19 immunization, reaction(s): "I hadn't had any problem with the first 3 doses"; Bnt162b2 (Dose: 2), for Covid-19 immunization, reaction(s): "I hadn't had any problem with the first 3 doses"; Bnt162b2 (Dose: 3), for COVID-19 Immunization, reaction(s): "I hadn't had any problem with the first 3 doses". The following information was reported: DRUG HYPERSENSITIVITY (hospitalization), outcome "unknown", described as "vaccine allergies/she experienced a reaction to the second booster of the Pfizer-BioNTech COVID-19 Vaccine gray cap".  Course of the event: Caller states she is calling about the Pfizer Covid19 vaccine and had a personal reaction and ended up in the hospital and has been discharged; states the first three covid19 vaccines she got were the purple cap and the one she got last week was the grey cap and she knows she has vaccine allergies and preservative allergies  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between the events and suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
This initial spontaneous case was received from a lawyer regarding a case in litigation concerning a female patient of unspecified age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2015, the patient was inoculated with ZOSTAVAX at a pharmacy for routine adult health maintenance for the prevention of shingles (dose, route, and lot # were not provided). The vaccine did not prevent shingles as intended and subsequently, the patient experienced vision loss. She was treated by an optometrist for the vision loss. As a direct and proximate result of ZOSTAVAX and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was not recovered/not resolved. Causality assessment was related. Upon internal review, vision loss was considered to be medically significant. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of generalized rash in a 76-year-old female patient who received SHINGRIX (batch number TP5E5, expiry date 15th November 2020) for prophylaxis. On 11th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 12th June 2018, 1 days after receiving SHINGRIX, the patient experienced generalized rash. The patient was treated with prednisone. On an unknown date, the outcome of the generalized rash was not recovered/not resolved. It was unknown if the reporter considered the generalized rash to be related to SHINGRIX. Additional details were provided as follows: This case was reported by pharm D intern. The patient received SHINGRIX on the left arm. The patient experienced a body rash over her left arm and torso. The patient did see her doctor and was prescribed Prednisone. A clarification request was raised to confirm if the rash was generalized or localized, however, this was the only reported information.
This case was reported by a healthcare professional and described the occurrence of rash aggravated in a male subject of unspecified age who was vaccinated with Twinrix (GlaxoSmithKline). At the time of reporting, the subject was a prisoner. There was no information provided regarding concomitant medications or medical history. Previous vaccination included 1st and 2nd dose of Twinrix (GlaxoSmithKline) given on unknown dates in 2009. The subject has had a worsening rash over the past 6 months. The only thing the healthcare professional could correlate it with was the Twinrix vaccination. The rash seemed to get worse after each injection and then would subside until receiving the next injections. On 23 July 2009 the subject received 3rd dose of Twinrix (detail unknown). On 31 July 2009, 8 days after vaccination with Twinrix, the subject experienced rash aggravated. A the time of reporting the outcome of the event was unspecified. Follow-up information was received on 31 August 2009, via physician's assistant, who reported a 23 year old male 2009 and it became worse with the 3rd injection. The physician's assistant considered the event may have been to Twinrix. Further evaluation of his records revealed that his rash wasn't reported until 01 May 2009, well after the first and second doses". The subject was referred to dermatology.
MMR vaccine given to a woman 15-16 weeks pregnant. Pregnancy Hx is G2P1. Her EDC: 08/13/2018. No current complications noted by OBGYN. US pending. Tdap vaccine was also given twice in 3 weeks. First dose given on 02/01/2018, and second dose 02/20/2018.
bilat thigh w/ red,macular,patch&on lt chest- 2x3cm to 4x7 cm;
Swelling, redness with warmth of right thigh. Benadryl, then Zyrtec 10mg chewable tabs, cool compress to area.